



Helmholtz Centre for Ocean
Research, Kiel, Germany
Competing interests: The
authors declare that no
competing interests exist.
Funding: See page 23
Received: 06 April 2021
Accepted: 18 April 2021
Published: 28 April 2021
Reviewing editor: Urszula
Krzych, Walter Reed Army
Institute of Research, United
States
Copyright Wichers et al. This
article is distributed under the
terms of the Creative Commons
Attribution License, which
permits unrestricted use and
redistribution provided that the
original author and source are
credited.
Common virulence gene expression in
adult first-time infected malaria patients
and severe cases
J Stephan Wichers1,2,3, Gerry Tonkin-Hill4, Thorsten Thye5, Ralf Krumkamp5,6,
Benno Kreuels7,8,9, Jan Strauss1,2,3†, Heidrun von Thien1,2,3, Judith AM Scholz1,
Helle Smedegaard Hansson10, Rasmus Weisel Jensen10, Louise Turner10,
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Abstract Sequestration of Plasmodium falciparum(P. falciparum)-infected erythrocytes to host
endothelium through the parasite-derived P. falciparum erythrocyte membrane protein 1 (PfEMP1)
adhesion proteins is central to the development of malaria pathogenesis. PfEMP1 proteins have
diversified and expanded to encompass many sequence variants, conferring each parasite a similar
array of human endothelial receptor-binding phenotypes. Here, we analyzed RNA-seq profiles of
parasites isolated from 32 P. falciparum-infected adult travellers returning to Germany. Patients
were categorized into either malaria naive (n = 15) or pre-exposed (n = 17), and into severe (n = 8)
or non-severe (n = 24) cases. For differential expression analysis, PfEMP1-encoding var gene
transcripts were de novo assembled from RNA-seq data and, in parallel, var-expressed sequence
tags were analyzed and used to predict the encoded domain composition of the transcripts. Both
approaches showed in concordance that severe malaria was associated with PfEMP1 containing the
endothelial protein C receptor (EPCR)-binding CIDRa1 domain, whereas CD36-binding PfEMP1 was
linked to non-severe malaria outcomes. First-time infected adults were more likely to develop
severe symptoms and tended to be infected for a longer period. Thus, parasites with more
pathogenic PfEMP1 variants are more common in patients with a naive immune status, and/or
adverse inflammatory host responses to first infections favor the growth of EPCR-binding parasites.
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Introduction
Despite considerable efforts during recent years to combat malaria, the disease remains a major
threat to public health in tropical countries. The most severe clinical courses of malaria are due to
infections with the protozoan species Plasmodium falciparum. In 2019, there were 229 million cases
of malaria worldwide, resulting in more than 400,000 deaths (WHO, 2020). Currently, about half of
the world’s population lives in infection-prone areas, and more than 90% of the malaria deaths occur
in Africa. In particular, children under five years of age and pregnant women suffer from severe dis-
ease, but adults from areas of lower endemicity and non-immune travelers are also vulnerable to
severe malaria. Both, children and adults are affected by cerebral malaria, but the prevalence of dif-
ferent features of severe malaria differs with increasing age. Anemia and convulsions are more fre-
quent in children, jaundice indicative of hepatic dysfunction and oliguric renal failure are the
dominant manifestations in adults (Dondorp et al., 2008; World Health Organization, 2014). More-
over, the mortality increases with age (Dondorp et al., 2008) and was previously determined as a
risk factor for severe malaria and fatal outcome in non-immune patients, but the causing factors are
largely unknown (Schwartz et al., 2001).
The virulence of Plasmodium falciparum (P. falciparum) is linked to the infected erythrocytes bind-
ing to endothelial cell surface molecules expressed on blood vessel walls. This phenomenon, known
as sequestration, prevents the passage of infected erythrocytes through the spleen, which would
otherwise remove the infected erythrocytes from the circulation and kill the parasite (Saul, 1999).
The membrane proteins mediating sequestration are exposed to the host’s immune system, and
through evolution, P. falciparum parasites have acquired several multi-copy gene families coding for
variant surface antigens, allowing immune escape through extensive sequence polymorphisms.
Endothelial sequestration is mediated by the P. falciparum erythrocyte membrane protein 1
(PfEMP1) family, the members of which have different binding capacities for host vascular tissue
receptors such as CD36, endothelial protein C receptor (EPCR), ICAM-1, PECAM1, receptor for
complement component C1q (gC1qR), and chondroitin sulphate (CSA) (Magallón-Tejada et al.,
2016; Turner et al., 2013; Rowe et al., 2009). The long, variable, extracellular PfEMP1 region
responsible for receptor binding contains a single N-terminal segment (NTS; main classes A, B, and
pam) and a variable number of different Duffy binding-like (DBL; main classes DBLa-z and pam) and
cysteine-rich inter-domain region domains (CIDR; main classes CIDRa-d and pam) (Rask et al.,
2010). These domains were initially allocated to subclasses (e.g., the DBLb subclasses 1–13); how-
ever, due to frequent recombinations between members of the different subclasses, many of these
are indistinct and poorly defined (Otto et al., 2019).
PfEMP1 molecules have been grouped into four categories (A, B, C, and E) depending on the
type of N-terminal domains (the PfEMP1 ‘head structure’) as well as the 5’ upstream sequence, the
chromosomal localization, and the direction of transcription of their encoding var gene (Rask et al.,
2010; Kyes et al., 2007; Kraemer and Smith, 2003; Lavstsen et al., 2003). Each parasite possesses
about 60 var genes with approximately the same distribution among the different groups
(Rask et al., 2010). About 20% of PfEMP1 variants belong to group A and are typically longer pro-
teins with a head structure containing DBLa1 and either an EPCR-binding CIDRa1 domain or a
CIDRb/g/d domain of unknown function. Further, the group A includes two conserved, strain-tran-
scendent subfamilies: the var1 subfamily (previously known as var1csa), found in two different var-
iants in the parasite population (3D7- and IT-type) (Otto et al., 2019), and the var3 subfamily, the
shortest var genes with only two extracellularly exposed domains (DBLa1.3 and DBLe8). Groups B
and C include most, about 75%, of PfEMP1 and typically have DBLa0-CIDRa2–6 head structures
binding CD36, followed by a DBLd1-CIDRb/g domain combination. A particular subset of B-type pro-
teins, also known as group B/A chimeric genes, possesses a chimeric DBLa0/1 domain (a.k.a.
DBLa2) and an EPCR-binding CIDRa1 domain. Thus, the head structure confers mutually exclusive
binding properties either to EPCR and CD36, or to an unknown receptor via the CIDRb/g/d domains.
C-terminally to the head structure, most group A and some group B and C PfEMP1 have additional
DBL domains, of which specific subsets of DBLb domains of group A and B PfEMP1 bind ICAM-1
(Lennartz et al., 2017; Janes et al., 2011), and another DBLb domain, DBLb12, has been suggested
to bind gC1qR (Magallón-Tejada et al., 2016). The consistent co-occurrence of specific domain
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subsets in the same PfEMP1 gave rise to the definition of domain cassettes (DCs) (Otto et al., 2019;
Berger et al., 2013; Rask et al., 2010). The best example of this is the VAR2CSA PfEMP1 (group E,
DC2), which binds placental CSA and causes pregnancy-associated malaria (Salanti et al., 2004).
The VAR2CSA proteins share domain composition, their encoding genes are less diversified than
other var groups, and all parasites possess one or two var2csa copies. Another example is the chime-
ric group B/A PfEMP1, also known as DC8, which includes DBLa2, specific CIDRa1.1/8 subtypes
capable to bind EPCR and typically DBLb12 domains.
Due to the sequence diversity of var genes, studies of var expression in patients have relied on
the analysis of DBLa-expressed sequence tags (EST) (Warimwe et al., 2009; Warimwe et al., 2012)
informing on relative distribution of different var transcripts and qPCR primer sets covering some,
but not all, subsets of DBL and CIDR domains (Lavstsen et al., 2012; Mkumbaye et al., 2017). So
far, only very few studies (Tonkin-Hill et al., 2018; Andrade et al., 2020; Duffy et al., 2016;
Kamaliddin et al., 2019) have used the RNA-seq technology to quantify assembled var transcripts in
vivo. Moreover, most studies have focused on the role of PfEMP1 in severe pediatric malaria.
A consensus from these studies is that severe malaria in children is associated with expression of
PfEMP1 with EPCR-binding CIDRa1 domains (Jespersen et al., 2016; Kessler et al., 2017;
Storm et al., 2019; Shabani et al., 2017; Mkumbaye et al., 2017; Magallón-Tejada et al., 2016),
but elevated expression of dual EPCR and ICAM-1-binding PfEMP1 (Lennartz et al., 2017) and the
group A-associated DC5 and DC6 have also been associated with severe disease outcomes (Magal-
lón-Tejada et al., 2016; Avril et al., 2013; Avril et al., 2012; Claessens et al., 2012;
Lavstsen et al., 2012; Duffy et al., 2019). Less effort has been put into understanding the role of
PfEMP1 in relation to severe disease in adults, and its different symptomatology and higher fatality
rate. Two gene expression studies from regions of unstable transmission in India showed elevated
expression of EPCR-binding variants (DC8, DC13) and DC6 (Bernabeu et al., 2016; Subudhi et al.,
2015), and also of transcripts encoding B- and C-type PfEMP1 in severe cases (Subudhi et al.,
2015).
In this study, we applied an improved genome-wide expression profiling approach using RNA-
seq to study gene expression, in particular var gene expression, in P. falciparum parasites from hos-
pitalized adult travellers and combined it with a novel prediction analysis of var transcripts from
DBLa EST. Individuals were clustered into (i) first-time infected (n = 15) and (ii) pre-exposed (n = 17)
individuals on the basis of serological data or into (iii) severe (n = 8) and (iv) non-severe (n = 24)
cases according to medical reports. Our multi-dimensional analysis revealed a clear association of
domain cassettes with EPCR-binding properties with a naive immune status and severe malaria,
whereas CD36-binding PfEMP1 proteins and the conserved var1-3D7 variant were expressed at
higher levels in pre-exposed patients and non-severe cases. Interestingly, severe complications
occurred only in the group of first-time infected patients, who also tended to be infected for a lon-
ger period, indicating that severity of infection in adults is dependent on duration of infection, host
immunity, and parasite virulence gene expression.
Results
Cohort characterization
This study is based on a cohort of 32 adult malaria patients hospitalized in Hamburg, Germany. All
patients had fever, indicative of symptomatic malaria. MSP1 genotyping estimated a low number of
different parasite genotypes present in the patients (Table 1). For 10 patients, the present malaria
episode was their first recorded P. falciparum infection. Nine individuals had previously experienced
malaria episodes according to the medical reports, whereas malaria exposure was unknown for 13
patients. In order to determine if patients already had an immune response to P. falciparum anti-
gens, indicative of previous exposure to malaria, plasma samples were analyzed by a Luminex-based
assay displaying the antigens AMA1, MSP1, and CSP (Supplementary file 1). Immune responses to
AMA1 and MSP1 are known to be long-lasting, and seroconversion to AMA1 is assumed to occur
only after a single or very few infections (Drakeley et al., 2005). Principal component analysis (PCA)
of the Luminex data resulted in separation of the patients into two discrete groups corresponding to
first-time infected adults (‘naive cluster’) and malaria pre-exposed individuals (‘pre-exposed cluster’)
(Figure 1A). The 13 patients with an unknown malaria exposure status could be grouped into either
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the naive or the pre-exposed group defined by the PCA of antigen reactivity. The only outlier in the
clustering was a 19-year-old patient (#21) from Sudan, who reported several malaria episodes during
childhood, but clustered with the malaria-naive patients.
Plasma samples were further subjected to (i) a merozoite-directed antibody-dependent respira-
tory burst (mADRB) assay (Kapelski et al., 2014), (ii) a parasitophorous vacuolar membrane-enclosed
merozoite structure (PEMS)-specific ELISA, and (iii) a protein microarray with 228 P. falciparum anti-
gens (Borrmann, 2020). Analysis of these serological assays in relation to the patient clustering con-
firmed the expected higher and broader antigen recognition by ELISA and protein microarray, and
the stronger ability to induce burst of neutrophils by serum from the group of malaria-pre-exposed
patients (Figure 1B–D, Supplementary file 1). Data from all the serological assays were next used
for an unsupervised random forest machine learning approach to build models predictive of
each individual’s protective status. A multidimensional scaling plot was used to visualize cluster allo-
cation, confirming the classification of patient #21 as being non-immune (Figure 1E). Patient #26,
positioned at the borderline to pre-exposed patients, was grouped into the naive cluster in accor-
dance with the Luminex data and the patient statement that this potentially pre-exposed patient
returned from his first trip to Africa. The calculated variable importance highlighted the relevance of
mADRB, ELISA, and Luminex assays to allocate patients into clusters (Figure 1F).
Using protein microarrays, the antibody response against described antigens was analyzed in
detail. As expected, pre-exposed individuals showed significantly elevated IgG antibody responses
against a broad range of parasite antigens, especially typical parasite blood stage markers, including
MSP1, MSP2, MSP4, MSP10, EBA175, REX1, and AMA1 (Figure 1D, upper panel). Markers for a
recent infection, MSP1, MSP4, GLURP, and ETRAMP5 (van den Hoogen et al., 2018), were signifi-
cantly elevated in the pre-exposed individuals in comparison to the defined first-time infected
group. In addition, further members of the ETRAMP family, including ETRAMP10, ETRAMP14,
ETRAMP10.2, and ETRAMP4, and also antibodies against pre-erythrocytic antigens, such as CSP,
STARP, and LSA3, were highly elevated. Similar effects were detectable for IgM antibodies; previous
exposure to the malaria parasite led to higher antibody levels (Figure 1D, lower panel).
Eight patients from the malaria-naive group were considered as having severe malaria based on
the predefined criteria. The remaining 24 cases were assigned to the non-severe malaria group
(Figure 1G, Supplementary file 2). Comparing the IgG antibody response of severe and non-severe
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Figure 1. Subgrouping of patients into first-time infected and pre-exposed individuals based on antibody levels against P. falciparum. In order to
further characterize the patient cohort, plasma samples (n = 32) were subjected to Luminex analysis with the Plasmodium falciparum (P. falciparum)
antigens AMA1, MSP1, and CSP, known to induce a strong antibody response in humans. With exception of patient #21, unsupervised clustering of the
PCA-reduced data clearly discriminates between first-time infected (naive) and pre-exposed patients with higher antibody levels against tested P.
falciparum antigens and also assigns plasma samples from patients with an unknown immune status into naive and pre-exposed clusters (A).
Classification of patient #21 into the naive subgroup was confirmed using different serological assays assessing antibody levels against P. falciparum on
different levels: a merozoite-directed antibody-dependent respiratory burst (mADRB) assay (Kapelski et al., 2014) (B), a parasitophorous vacuolar
membrane-enclosed merozoite structure (PEMS)-specific ELISA (C), and a 262-feature protein microarray covering 228 well-known P. falciparum
antigens detecting reactivity with individual antigens, and the antibody breadth of IgG (upper panel) and IgM (lower panel) (D). The boxes represent
medians with IQR; the whiskers depict minimum and maximum values (range), with outliers located outside the whiskers. Serological assays revealed
significant differences between patient groups (Mann-Whitney U test). Reactivity of patient plasma IgG and IgM with individual antigens in the protein
microarray is presented as the volcano plot, highlighting the significant hits in red. Box plots represent antibody breadths by summarizing the number
of recognized antigens out of 262 features tested. Data from all assays were used for an unsupervised random forest approach (E). The variable
importance plot of the random forest model shows the decrease in prediction accuracy if values of a variable are permuted randomly. The decrease in
accuracy was determined for each serological assay, indicating that the mADRB, ELISA, and Luminex assays are most relevant in the prediction of
patient clusters (F). Venn chart showing the patient subgroups used for differential expression analysis (G). Patients with a known immune status based
on medical reports were marked in all plots with filled circles in blue (naive) and grey (pre-exposed), and samples from patients with an unknown
immune status are shown as open circles. Patient #21 is shown as a filled circle in grey with a cross, and patient #26 is represented by an open circle
with a cross. ELISA: enzyme-linked immunosorbent assay; IQR: interquartile range; PCA: principal component analysis.
The online version of this article includes the following figure supplement(s) for figure 1:
Figure supplement 1. Early immune response in mild and severe malaria within the naive patient cluster.
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cases within the previously malaria-naive group, elevated antibody levels were found in the severe
subgroup. The highest fold change was observed for antibodies directed against intracellular pro-
teins, such as DnaJ protein, GTPase-activating protein, or heat shock protein 70 (Figure 1—figure
supplement 1). Interestingly, IgM antibodies against ETRAMP5 were detectable in the severely
infected individuals, suggesting they were infected for a prolonged period of time compared to the
mild malaria population (Helb et al., 2015; van den Hoogen et al., 2018).
RNA-seq transcriptomics
Parasites were isolated from the venous blood of all patients for subsequent transcriptional profiling
(Figure 2A). Transcriptome libraries were sequenced for all 32 patient samples (NCBI BioProject ID:
PRJNA679547). The number of trimmed reads ranged between 29,142,684 and 82,000,248 (median:
41,383,289) within the individual libraries derived from patients. The proportion of total reads spe-
cific for P. falciparum was 87.7% (median; IQR 76.7–91.3) for the 30 samples included in the de novo
assembly (Supplementary file 3). Variation in parasite ages – defined as the progression of the intra-
erythrocytic development cycle measured in hours post invasion – in the different patient samples
was analyzed with a mixture model in accordance with Tonkin-Hill et al., 2018, using the published
data from López-Barragán et al., 2011. Parasites from first-time infected and pre-exposed patients
revealed no obvious difference in the proportion of the different parasite stages or in median age
(Table 1, Figure 2—figure supplement 1). However, a small, statistically not significant bias
(p=0.17) towards younger parasites in the severe cases was observed with a median age of 8.2 hours
post infection (hpi) (IQR 8.0–9.8) in comparison to 9.8 hpi in the non-severe cases (IQR 8.2–11.4)
(Table 1, Figure 2—figure supplement 1D). None of the samples revealed high proportions of late
trophozoites (all <3%), schizonts (0%), or gametocytes (all <6%) (Figure 2—figure supplement 1A,
B). The estimated proportions were used to control for differences in parasite stages between sam-
ples by including them as covariates in the regression analysis of differential core gene expression
(Figure 2A, Figure 2—figure supplement 2).
Genome-wide analysis of differential gene expression
Global gene expression analysis according to Tonkin-Hill et al., 2018 identified 420 genes to be
higher and 236 to be lower expressed (p0.05) in first-time infected patients, together correspond-
ing to 11.3% of all P. falciparum genes (Supplementary file 4). Similarly, 362 genes were signifi-
cantly higher and 219 genes lower expressed in severe cases (Supplementary file 5). A gene set
enrichment analysis (GSEA) of the differentially expressed genes using Gene Ontology (GO) terms
and KEGG pathway annotations showed that the KEGG pathway 03410 ‘base excision repair’ facili-
tating the maintenance of genome integrity by repairing small base lesions in the DNA was
expressed at significantly higher levels in first-time infected patient samples (Figure 2B, Figure 2—
figure supplement 3). In total, six out of 15 P. falciparum genes included in this KEGG pathway
were found to be statistically significantly enriched upon first-time infection, including the putative
endonuclease III (PF3D7_0614800) from the short-patch pathway and the putative A-/G-specific ade-
nine glycosylase (PF3D7_1129500), the putative apurinic/apyrimidinic endonuclease Apn1
(PF3D7_1332600), the proliferating cell nuclear antigens 1 (PF3D7_1361900), and the catalytic
(PF3D7_1017000) and small (PF3D7_0308000) subunits from the DNA polymerase delta from the
long-patch pathway (Figure 2C). Additionally, a significantly lower expression level for genes associ-
ated with several GO terms involved in antigenic variation and host cell remodeling was found in
first-time infected patients (Figure 2B, Supplementary file 4) and severe cases (Supplementary file
5).
As variant surface antigens like var, rif, and stevor are largely clone-specific, analysis of reads
from the clinical isolates mapping to homologous regions in 3D7 genes would be distorted and
flawed. Therefore, we analyzed var gene expression first by de novo assembling var genes from the
RNA-seq data and subsequently analyzing the expression of specific var gene subsets according to
the domains encoded. In addition, we manually screened differentially expressed genes known to be
involved in var gene regulation or the correct display of PfEMP1 at the host cell surface
(Supplementary file 4, 5).
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Figure 2. Overview of the methodology and differential core gene expression analysis. Summary diagram of the approaches taken to analyze the
differential expression of core and var genes. In principle, all samples were analyzed by sequencing of the RNA using next generation sequencing
(NGS) and by sequencing of expressed sequence tags (EST) from the DBLa domain (A). Gene set enrichment analysis (GSEA) of gene ontology (GO)
terms and KEGG pathways indicate gene sets deregulated in first-time infected malaria patients. GO terms related to antigenic variation and host cell
remodeling are significantly overrepresented in the down-regulated gene set; only the KEGG pathway 03410 ‘base excision repair’ shows a significant
Figure 2 continued on next page
Wichers et al. eLife 2021;10:e69040. DOI: https://doi.org/10.7554/eLife.69040 7 of 30
Research article Chromosomes and Gene Expression Microbiology and Infectious Disease
Differential var gene expression
To correlate individual var genes or common var gene-encoded traits (Figure 3) with a naive immune
status or disease severity, differential var transcript levels were analyzed as in Tonkin-Hill et al.,
2018;Figure 2A, Figure 2—figure supplement 2. Var transcripts were assembled from each patient
sample separately and annotated. In total, 6441 contigs with over 500 bp lengths were generated
with an N50 of 2302 bp and a maximum length of 10,412 bp (Source data 1.). A median of 200 con-
tigs (IQR: 137–279) with lengths >500 bp was assembled per sample. One or more DBL or CIDR
domains could be annotated to 5488 of the contigs, whereas the remaining contigs could only be
annotated by these smaller domain building blocks, the so-called homology blocks as defined by
Rask et al., 2010; Supplementary file 6, 7.
Differential var transcript levels
We first looked for highly similar transcripts present in multiple samples. The Salmon RNA-seq quan-
tification pipeline (Patro et al., 2017), which identifies equivalence classes allowing reads to contrib-
ute to the expression estimates of multiple transcripts, was used to estimate expression levels for
each transcript. Due to the high diversity in var genes, mainly assembled transcripts of the strain-
transcendent variants var1, var2csa, and var3 were found to be differentially expressed. Notably, the
var1-IT variant was expressed at higher levels in parasites from first-time infected patients, whereas
the var1-3D7 variant was expressed at higher levels in parasites from pre-exposed and non-severe
patients (Figure 4A,B, Figure 5A,B, Supplementary file 9, 10). This was confirmed by mapping nor-
malized reads from all patients to both var1 variants as well as var2csa (Figure 3—figure supple-
ment 1). Beyond the conserved variants, several var fragments from B- or C-type var genes were
associated with a naive immune status, and three transcripts from A-, DC8-, and B-type var genes as
well as var2csa were linked to severe malaria patients (Figures 4 and 5, Supplementary file 9, 10).
Differential var domain transcript levels
To assess the differential expression of specific var domains, read counts corresponding to domains
with the same classification were calculated. This showed that different EPCR-binding CIDRa1
domain variants and other domains found in DC with CIDRa1 domains were expressed at signifi-
cantly higher levels in first-time infected patients (Figure 4C–E, Supplementary file 9). Specifically,
besides domains from DC8 (DBLa2, CIDRa1.1, DBLb12) and DC13 (DBLa1.7, CIDRa1.4), the
CIDRa1.7 and DBLa1.2 (DC15) domains were increased upon infection of malaria-naive individuals.
The DBLa1.2 domain was, in all of the 32 gene assemblies, flanked by an EPCR-binding CIDRa1
domain, and 56% of these were a CIDRa1.5 domain (Supplementary file 6, 7). In addition, parasites
from first-time infected patients showed a significantly higher level of transcripts encoding the
CIDRd1 domain of DC16 (DBLa1.5/6-CIDRd1/2) and the DBLb6 domain (Figure 4D–E). The DBLb6
domain is associated with A-type var genes and can be found adjacent to DC15 and DC16
(Otto et al., 2019; Supplementary file 6, 7). In general, domains associated with the same domain
cassette showed the same trend even if some domains did not reach statistical significance set at
p<0.05 (Supplementary file 9).
Domains found expressed at lower levels in malaria-naive individuals included group B and C
N-terminal head structure domains NTSB and DBLa0.13/22/23, and CD36-binding CIDR domains
(CIDRa2.8/9,6) as well as the C-terminal CIDRg11 domain and domains of the var1-3D7 variant
(DBLa1.4, DBLg15, DBLe5) (Figure 4C–E).
Figure 2 continued
up-regulation in malaria-naive patients (B). Log fold changes (logFC) for the 15 Plasmodium falciparum (P. falciparum) genes assigned to the KEGG
pathway 03410 ‘base excision repair’ are plotted with the six significant hits marked with * p<0.05 and **p<0.01 (C).
The online version of this article includes the following figure supplement(s) for figure 2:
Figure supplement 1. Estimated stage proportions for each sample.
Figure supplement 2. Summary diagram of the approaches taken to analyze the RNA-seq data.
Figure supplement 3. The base excision repair (KEGG:03410) in P. falciparum.
Figure supplement 4. RNA quality.
Wichers et al. eLife 2021;10:e69040. DOI: https://doi.org/10.7554/eLife.69040 8 of 30
Research article Chromosomes and Gene Expression Microbiology and Infectious Disease
Figure 3. Summary of PfEMP1 transcripts, domains, and homology blocks that were found more or less frequently in malaria-naive and severely ill
patients. A schematic presentation of all var gene groups with their associated binding phenotypes and typical PfEMP1 domain compositions. The
N-terminal head structure confers mutually exclusive receptor-binding phenotypes: EPCR (beige: CIDRa1.1/4–8), CD36 (turquoise: CIDRa2–6), CSA
(yellow: VAR2CSA), and yet unknown phenotypes (brown: CIDRb/g/d; dark red: CIDRa1.2/3 from VAR1, VAR3). Group A includes the conserved
subfamilies VAR1 and VAR3, EPCR-binding variants, and those with unknown binding phenotypes conferred by CIDRb/g/d domains. Group B PfEMP1
can have EPCR-binding capacities, but most variants share a four-domain structure, with group C-type variants capable of CD36 binding. Dual binders
can be found within groups A and B, with a DBLb domain after the first CIDR domain responsible for ICAM-1 (DBLb1/3/5) or gC1qr binding (DBLb12)
(A). Transcripts, domains, and homology blocks according to Rask et al., 2010 as well as domain predictions from the DBLa-tag approach were found
to be significantly differently expressed (p-value<0.05) between patient groups of both comparisons: first-time infected (blue) versus pre-exposed
(black) cases and severe (red) versus non-severe (black) cases (B). ATS: acidic terminal sequence; CIDR: cysteine-rich interdomain region; CSA:
chondroitin sulphate A; DBL: Duffy binding-like; DC: domain cassette; EPCR: endothelial protein C receptor; gC1qr: receptor for complement
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When comparing severe to the non-severe cases, domains of DC8 (DBLa2, CIDRa1.1, DBLb12),
DC15 (DBLa1.2), and DC16 (DBLa1.6) and the A-type-linked DBLb6 were found associated with
severe disease. Domain types expressed at significantly higher levels in non-severe cases included
N-terminal head structure domains, DBLa0.23, CIDRa2.4/9 from group B and C PfEMP1, DC16
(DBLa1.5), and the CIDRa1.3 domain from the var1-3D7 allele (Figure 5C–E, Supplementary file
10).
As DBL and CIDR subclasses are poorly defined (Otto et al., 2019) and different domain sub-
classes confer the same binding phenotype (Higgins and Carrington, 2014), the domains of the
N-terminal head structure were grouped according to their binding phenotype and the normalized
read counts (transcripts per million [TPM]) were summarized for each patient (Figures 4F and
5F). This showed significant differences for domains associated with EPCR- or CD36-binding
PfEMP1. As expected, domains associated with EPCR-binding as well as the CIDRg3 domain were
expressed at higher levels in naive and more severe cases, whereas domains associated with the
CD36-binding phenotype were higher expressed in pre-exposed and non-severe patients.
Differential var homology block transcript levels
PfEMP1 domains have been described as composed of 628 homology blocks (Rask et al., 2010).
Homology block expression levels were obtained by aggregating read counts for each block after
first identifying all occurrences of the block within the assembled contigs. Transcripts encoding block
numbers 255, 584, and 614, all typically located within DBLb domains of DC8- and CIDRa1-contain-
ing type A PfEMP1 (Figure 4G,H, Supplementary file 9), number 557, located in the interdomain
region between DBLb and DBLg domains (no PfEMP1 type association), and block number 155,
found in NTSA, were found associated with a naive immune status. Conversely, transcripts encoding
block number 88 from DBLa0 domains and 269 from ATSB were found at lower levels in malaria-
naive patients, indicating that B- and C-type genes are more frequently expressed in pre-exposed
individuals (Figure 4G,H, Supplementary file 9). No homology blocks were associated with severe
cases, but two blocks, 591 and 559, found in group B PfEMP1, were found to be lower expressed in
severe malaria cases (Figure 5G,H, Supplementary file 10).
Var expression profiling by DBLa-tag sequencing
To supplement the RNA-seq analysis with an orthogonal analysis, we conducted deep sequencing of
RT-PCR-amplified DBLa ESTs from 30 of the patient samples (Lavstsen et al., 2012; Figure 2A).
Between 851 and 3368 reads with a median of 1666 over all samples were analyzed. Identical DBLa-
tag sequences were clustered to generate relative expression levels of each unique var gene tag.
Overall, the relative expression levels were similar for sequences found in both the RNA-seq and the
DBLa-tag approach with a mean log2(DBLa-PCR/RNA-seq) ratio of 0.4 (CI of 95%:  2.5–3.3) deter-
mined by Bland-Altman plotting (Figure 6—figure supplement 1). Around 82.6% (median) of all
unique DBLa-tag sequences detected with >10 reads (92.9% of all DBLa-tag sequences) were found
in the RNA-seq approach, and 81.8% of the upper 75th percentile of RNA-seq contigs (spanning
across the DBLa-tag region) were found by the DBLa-tag approach.
Using the Varia tool (Mackenzie et al., 2020), the domain composition of the var genes from
which the DBLa-tag sequences originated was predicted. The tool searches an extended varDB
containing >200K annotated var genes for genes with near identical DBLa-tag sequences and
returns the consensus domain annotation among the hit sequences. A partial domain annotation was
made for ~85% of the DBLa-tag sequences (Figure 2A, Supplementary file 11). In line with the
RNA-seq data, this analysis showed that DBLa1 and DBLa2 sequences were enriched in first-time
infected and severe malaria patients. Conversely, a significant higher proportion of DBLa0 sequen-
ces was found in pre-exposed individuals and mild cases (Figure 6A,B). No difference was observed
Figure 3 continued
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The online version of this article includes the following figure supplement(s) for figure 3:
Figure supplement 1. Differential expression of the var1 variants 3D7 and IT and var2csa between patient groups.
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Figure 4. Expression differences between parasites from first-time infected and pre-exposed patients at the level of var gene transcripts, domains, and
homology blocks determined by NGS. RNA-seq reads of each patient sample were matched to de novo assembled var contigs with varying lengths,
domains, and homology block compositions. Shown are significantly differently expressed var gene contigs (A, B) as well as PfEMP1 domain subfamilies
(C–F) and homology blocks (G, H) from Rask et al., 2010, with an adjusted p-value of <0.05. Data are displayed as heat maps showing expression
Figure 4 continued on next page
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in the number of reads or unique DBLa-tags detected between patient groups, although a trend
towards more DBLa-tag clusters was observed in first-time infected patients and severe cases
(Figure 6A,B). Prediction of the NTS and CIDR domains flanking the DBLa domain showed a signifi-
cantly higher proportion of NTSA in severe cases as well as EPCR-binding CIDRa1 domains in first-
time infected and severe cases. Expression of var genes encoding NTSB and CIDRa2–6 domains was
significantly associated within pre-exposed and non-severe cases (Figure 6A,B). Subsequent analysis
of var expression in relation to other domains showed that var transcripts with DBLb, g, and z or
CIDRg domains were more frequently expressed in first-time infected and severe malaria patients
whereas those encoding DBLd and CIDRb were less frequent (Figure 6—figure supplement 2).
Assessing expression in relation to the domain subtype, CIDRa1.1/5, DBLb12, DBLg2/12, DBLa2,
DBLa1.2/2, and DBLd5 (together with DBLg12 components of the DC5) were found associated with
severe malaria, while CIDRa3.1/4, DBLa0.12/16, and DBLd1 were associated with non-severe cases
(Figure 6—figure supplement 2).
Overall, these data corroborate the main observations from the RNA-seq analysis, confirming the
association of EPCR-binding PfEMP1 variants with development of severe malaria symptoms and
CD36-binding PfEMP1 variants with establishment of less severe infections in semi-immune
individuals.
Correlation of var gene expression with antibody levels against head
structure CIDR domains
A detailed analysis of the antibody repertoire of the patients against head structure CIDR domains
of PfEMP1 was carried out using a panel of 19 different EPCR-binding CIDRa1 domains, 12 CD36-
binding CIDRa2–6 domains, three CIDRd1 domains as well as a single CIDRg3 domain (Obeng-
Adjei et al., 2020; Bachmann et al., 2019). Additionally, the minimal binding region of VAR2CSA
was included. In general, plasma samples from malaria-naive as well as severe cases showed lower
mean fluorescence intensity (MFI) values for all antigens tested in comparison to samples from pre-
exposed or non-severe cases with significant differences for CIDRa2–6, CIDRd1, and CIDRg3, but
not for EPCR-binding CIDRa1 domains (Figure 7A,B).
Data were also analyzed using the average MFI reactivity (plus two standard deviations) of a Dan-
ish control cohort as a cut off for seropositivity to calculate the coverage of antigen recognition
(Supplementary file 1; Cham et al., 2010). In this analysis, almost half of the tested antigens were
recognized by pre-exposed (median: 47.2%) and non-severe patients (median: 44.4%), but only 1/4
of the antigens were recognized by first-time infected patients (median: 25.0%) and 1/20 by severely
ill patients (median: 5.6%). PfEMP1 antigens recognized by over 60% of the pre-exposed and/or
non-severe patient sera were (i) four CIDRa1 domains capable of EPCR-binding (CIDRa1.5,
CIDRa1.6, CIDRa1.7, and the DC8 domain CIDRa1.8), (ii) two CD36-binding CIDRa domains
(CIDRa2.10, CIDRa3.1), and (iii) two CIDR domains with unknown binding phenotypes (CIDRd1 and
CIDRg3) (Figure 7C, Supplementary file 1).
Taken together, this analysis indicates that higher levels of antibodies against severe malaria-
associated EPCR-binding variants are present in pre-exposed and non-severe cases, which might
have selected against parasites expressing CIDRa1 domains during the current infection.
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Figure 5. Expression differences between parasites from severe and non-severe cases at the level of var gene transcripts, domains, and homology
blocks determined by NGS. RNA-seq reads of each patient sample were matched to de novo assembled var contigs with varying lengths, domains, and
homology block compositions. Shown are significantly differently expressed var gene contigs (A, B) as well as PfEMP1 domain subfamilies (C–F) and
homology blocks from Rask et al., 2010, with an adjusted p-value of <0.05 in severe (red) and non-severe patient samples (grey) (A, B). Data are
Figure 5 continued on next page
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Discussion
Non-immune travellers and adults from areas of unstable malaria transmission are prone to severe
malaria. Currently, only scarce information on the PfEMP1-mediated pathogenicity responsible for
the different symptomatology in comparison to paediatric severe malaria and the higher fatality rate
in adults is available. Here, we present the first in-depth gene expression analysis of 32 ex vivo blood
samples from adult travellers using RNA-seq and expressed sequence tag analyses. Despite the rela-
tively low number of patient samples recruited in 5 years, our data confirmed previously reported
associations between transcripts encoding type A and B EPCR-binding PfEMP1 and infections in
naive hosts and disease severity (Duffy et al., 2019; Tonkin-Hill et al., 2018; Kessler et al., 2017;
Bernabeu et al., 2016; Jespersen et al., 2016; Lavstsen et al., 2012). Our results further suggest
that parasite interaction with EPCR is linked to severe disease in children as well as in adults. How-
ever, since CIDRa1-containing PfEMP1 possess multiple binding traits (Lennartz et al., 2017; Mag-
allón-Tejada et al., 2016), co-interaction with other receptors may further increase the risk for
severe malaria.
Overall, there was a high degree of consensus between observations made on var expression
analyzed at different levels of PfEMP1 domain annotation. Stratifying var gene expression according
to the different main and subtypes of DBL and CIDR domains showed only A- and DC8-type PfEMP1
domains, and predominantly those linked to EPCR-binding PfEMP1, to be associated with first-time
infections. Conversely, domains typical for CD36-binding PfEMP1 proteins were found at higher lev-
els in malaria-experienced adults. Specifically, expression of PfEMP1 domains included in DC8,
DC13, and DC15 as well as all EPCR-binding CIDRa1 domains was associated with first-time adult
infections, whereas DBLa0- and CD36-binding CIDRa2–6 domains were linked to pre-exposed indi-
viduals. These differences were largely due to the differential expression between the first-time
infected patients with more severe symptoms and patients with non-severe malaria. Here, domains
of DC8 and DC15 as well as all DBLa1/2 and CIDRa1were associated with severe symptoms, while
NTSB, DBLa0, and CIDRa2–6 domains, including specific subsets of CIDRa2, were linked to non-
severe symptoms. These conclusions were closely mirrored in the DBLa-tag analysis and were further
corroborated by the differential RNA-seq expression stratified according to the smaller homology
blocks, which identified mainly homology blocks of DBLb1, -3, -5, and -12 to be associated with first-
time infected patients. These DBLb domains are parts of DCs associated with EPCR binding; so it is
hard to distinguish between co-occurring domains and clear associations.
In addition, three other group A PfEMP1-associated domains, CIDRg3, CIDRd from DC16, DBLb9
from DC5, and DBLb6 were found to be associated with first-time infected patients. DBLb9 and
DBLb6 could have been detected due to their presence C-terminally to some EPCR-binding or
A-type PfEMP1. However, the CIDRd domain of DC16 (DBLa1.5/6-CIDRd1/2) constitutes a different
subset of A-type PfEMP1, which, together with CIDRb2- and CIDRg3-containing group A PfEMP1
(found in DC11), may be associated with rosetting (Carlson et al., 1990; Ghumra et al., 2012).
Direct evidence that any of these CIDR domains have intrinsic rosetting properties is lacking
(Rowe et al., 2002). Rather, their association with rosetting may be related to their tandem expres-
sion with DBLa1 at the N-terminal head (Ghumra et al., 2012). The DC16 group A signature was
not associated with severe disease outcomes in previous DBLa-tag studies or qPCR studies by
Lavstsen et al., 2012 and Bernabeu et al., 2016, but DBLa1.5/6 and CIDRd of DC16 were enriched
in cerebral malaria cases with retinopathy in the study of Shabani et al., 2017 and Kessler et al.,
2017 using the same qPCR primer set. Also, the association of DC11 with severe malaria in Indone-
sia was found using the same RNA-seq approach as used here (Tonkin-Hill et al., 2018). Rosetting is
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thought to enhance microvascular obstruction, but its role in severe malaria pathogenesis remains
unclear (McQuaid and Rowe, 2020). However, together with previous observations, our data sug-
gest that paediatric cerebral malaria infections are dominated by the expansion of parasites express-
ing EPCR-binding domains accompanied by parasites expressing other group A PfEMP1, possibly
acting as rosetting variants. This was consistent with the more frequent recognition of CIDRa1
domains than CIDRa2–6 domains in pre-exposed patients, indicating that IgG against EPCR-binding
CIDR domains were acquired before IgG to other CIDR domains, as has been observed for malaria
endemic populations (Obeng-Adjei et al., 2020; Cham et al., 2009; Cham et al., 2010;
Turner et al., 2015).
Figure 6. Verification of RNA-seq results using DBLa-tag sequencing. Amplified DBLa-tag sequences were
blasted against the ~2400 genomes on varDB (Otto, 2019) to obtain subclassification into DBLa0/1/2 and
prediction of adjacent head structure N-terminal segment (NTS) and cysteine-rich interdomain region (CIDR)
domains and their related binding phenotype. Proportion of each NTS and DBLa subclass as well as CIDR
domains grouped according to the binding phenotype (CIDRa1.1/4–8: EPCR-binding, CIDRa2–6: CD36-binding,
CIDRb/g/d: unknown binding phenotype/rosetting) was calculated and shown separately on the left,
and the number of total reads and individual sequence cluster with n  10 sequences are shown on the right.
Differences in the distribution among first-time infected (blue) and pre-exposed individuals (grey) (A) as well as
severe (red) and non-severe cases (grey) (B) were tested using the Mann-Whitney U test. The boxes represent
medians with IQR; the whiskers depict minimum and maximum values (range) with outliers located outside the
whiskers.
The online version of this article includes the following figure supplement(s) for figure 6:
Figure supplement 1. Comparison of DBLa-tag sequencing with RNA-seq analysis.
Figure supplement 2. Quantile regression analysis of Varia outputs.
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Data from adult cohorts are rather limited, restricting our comparison mainly to three var gene
expression studies based on qPCR or a custom cross-strain microarray (Argy et al., 2017;
Bernabeu et al., 2016; Subudhi et al., 2015), but the majority of cases from the Indonesian RNA-
seq study are also adults (Tonkin-Hill et al., 2018). A high expression of A- and B-type var genes
and an association of DC4, -8, and -13 with disease severity has been reported for malaria cases
imported to France (Argy et al., 2017), and parasites from severe Indian adults show an elevated
expression of DC6, -8 (Bernabeu et al., 2016), and DC13 (Subudhi et al., 2015). In the severe cases
from Indonesia, mainly the DCs 4, 8, and 11 were found on an elevated level (Tonkin-Hill et al.,
2018). All studies are in agreement with the expression data from our cohort of adult travellers,
although we here in addition found a higher expression of DC15 (EPCR binding) and DC16 (putative
rosetting variants) var genes in malaria-naive patients.
Measurements of the total abundances of the different var groups are challenging (e.g., due dif-
ferences in the coverage or sensitivity of qPCR or DBLa-tag primer pairs targeting the different var
groups), but there is cumulative evidence that CIDRa1-containing transcripts are dominating the
Figure 7. Correlation of var gene expression with antibody levels against head structure CIDR domains. Patient
plasma samples (n = 32) were subjected to Luminex analysis with 35 PfEMP1 head structure cysteine-rich
interdomain region (CIDR) domains. The panel includes endothelial protein C receptor (EPCR)-binding CIDRa1
domains (n = 19), CD36-binding CIDRa2–6 domains (n = 12), and CIDR domains with unknown binding
phenotypes (CIDRg3: n = 1, CIDRd1: n = 3) as well as the minimal binding region of VAR2CSA (VAR2). Box plots
showing mean fluorescence intensities (MFI) extending from the 25th to the 75th percentile with a line at the
median indicate the higher reactivity of the pre-exposed (A) and non-severe cases (B) with all PfEMP1 domains
tested. Significant differences were observed for recognition of CIDRa2–6, CIDRd1, and CIDRg3; VAR2CSA
recognition differed only between severe and non-severe cases (Mann-Whitney U test). Furthermore, the breadth
of IgG recognition (%) of CIDR domains for the different patient groups was calculated and shown as a heat map
(C).
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infection in children with severe malaria, severe anemia, and cerebral malaria, and transcripts with
CIDRa2–6 domains are most abundantly expressed during uncomplicated malaria (Jespersen et al.,
2016; Duffy et al., 2019; Warimwe et al., 2009; Warimwe et al., 2012). Although the median
expression of CIDRa2–6 is lower in first-time infected and severe cases compared to pre-exposed
and non-severe cases, in most of our adult patients, CD36-binding var transcripts appear to domi-
nate the expression pattern. This is in concordance with all three other adult studies also indicating a
substantial expression of B- and C-type variants associated with the binding of CD36 (Argy et al.,
2017; Bernabeu et al., 2016; Subudhi et al., 2015), and (Subudhi et al., 2015) even showed an
association with complicated adult malaria. Maybe parasite binding to CD36 is specifically enhanced
in adult severe malaria cases compared to children, which is interesting due to their different disease
symptomatology (Dondorp et al., 2008; Schwartz et al., 2001). Alternatively, our adult cohort dif-
fers not only in age but also in terms of disease severity from paediatric cohorts, and less sick
patients may simply have a less dominant expression of EPCR-binding variants. However, for the par-
asite’s survival and transmission, it may be highly beneficial to express more of the less virulent
PfEMP1 variants that are able to bind CD36. This interaction may not, or is less likely to, result in
obstruction of blood flow, inflammation, and organ failure at least of the brain, where CD36 is nearly
absent (Turner et al., 1994).
To the best of our knowledge, this study is the first description of expression differences between
the two var1 variants, 3D7 and IT. The var1-IT variant was found enriched in parasites from first-time
infected patients, whereas several transcripts of the var1-3D7 variant were increased in pre-exposed
and non-severely ill patients. Expression of var1 gene was previously observed to be elevated in
malaria cases imported to France with an uncomplicated disease phenotype (Argy et al., 2017). In
general, the var1 subfamily is ubiquitously transcribed (Winter et al., 2003; Duffy et al., 2006),
atypically late in the cell cycle after transcription of var genes encoding the adhesion phenotype
(Kyes et al., 2003; Duffy et al., 2002; Dahlbäck et al., 2007) and is annotated as a pseudogene in
3D7 due to a premature stop codon. Similarly, numerous isolates display frame-shift mutations often
in exon two in the full gene sequences (Rask et al., 2010). However, none of these studies
addressed the differences in the two var1 variants that were recently identified by comparing var
gene sequences from 714 P. falciparum genomes (Otto et al., 2019), and to date, it is still unclear if
both variants fulfill the same function or have the same characteristics as previously described. Over-
all, the var1 gene – the first 3.2 kb of the 3D7 variant in particular – seems to be under high evolu-
tionary pressure (Otto et al., 2019), and both variants can be traced back before the split of P.
reichenowi from P. praefalciparum and P. falciparum (Otto et al., 2018b). Our data indicate that the
two variants, VAR1-3D7 and VAR1-IT, may have different roles during disease; however, this remains
to be determined in future studies.
In summary, our data show a significant increase in transcripts encoding EPCR-binding and other
A-type variants in parasites from severe and first-time infected patients. Conversely, transcripts of
CD36-binding variants are found more frequently in parasites from non-severe and pre-exposed
patients. Since CD36-binding variants are still overrepresented in all groups of adult malaria patients,
we postulate that the parasite population in first-time infected individuals may have a broad binding
potential after liver release as there is no pre-existing immunity to clear previously experienced
PfEMP1 variants. During the blood-stage infection, selection towards EPCR binding and other
A-type variants, which may confer a parasite growth advantage and also increase the risk for severe
malaria, may already have occurred in our adult severe malaria patients as indicated by the longer
period of infection.
Materials and methods
Blood sampling and processing
EDTA blood samples (1–30 mL) were obtained from the adult patients. The plasma was separated
by centrifugation and immediately stored at  20˚C. Erythrocytes were isolated by Ficoll gradient
centrifugation followed by filtration through Plasmodipur filters (EuroProxima) to clear the remaining
granulocytes. An aliquot of erythrocytes (about 50–100 ml) was separated and further processed for
gDNA purification. At least 400 ml of purified erythrocytes were rapidly lysed in five volumes of pre-
warmed TRIzol (ThermoFisher Scientific) and stored at  80˚C until further processing.
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Serological assays
Luminex assay
The Luminex assay was conducted as previously described using the same plex of antigens tested
(Bachmann et al., 2019). In brief, plasma samples from patients were screened for the individual rec-
ognition of 19 different CIDRa1, 12 CIDRa2–6, three CIDRd1 domains, and a single CIDRg3 domain
as well as of the controls AMA1, MSP1, CSP, VAR2CSA (VAR2), tetanus toxin (TetTox), and bovine
serum albumin (BSA). The data are shown as MFI, allowing comparison between different plasma
samples, but not between different antigens. Alternatively, the breadth of antibody recognition (%)
was calculated using MFI values from Danish controls plus two standard deviations (SD) as cut off.
Merozoite-triggered antibody-dependent respiratory burst
The assay to determine the mADRB activity of the patients was set up as described before
(Kapelski et al., 2014). Polymorphonuclear neutrophil granulocytes (PMNs) from one healthy volun-
teer were isolated by a combination of dextran-sedimentation and Ficoll-gradient centrifugation.
Meanwhile, 1.25  106 merozoites were incubated with 50 ml of 1:5 diluted plasma (decomple-
mented) from adult patients as well as from established negative and positive control donors for 2
hr. The opsonized merozoites were pelleted (20 min, 1500 g), re-suspended in 25 ml Hanks’ Balanced
Salt Solution (HBSS), and then transferred to a previously blocked well of an opaque 96-well high-
binding plate (Greiner Bio-One). Chemiluminescence was detected in HBSS using 83.3 mM luminol
and 1.5  105 PMNs at 37˚C for 1 hr to characterize the PMN response, with readings taken at 2-min
intervals using a multiplate reader (CLARIOstar, BMG Labtech). PMNs were added in the dark,
immediately before readings were initiated.
ELISA
Antibody reactivity against PEMS was estimated by ELISA. PEMS were isolated as described before
(Llewellyn et al., 2015). For ELISA, 0.625  105 PEMS were coated on the ELISA plates in PBS.
Plates were blocked using 1% Casein (Thermo Scientific #37528) and incubated for 2 hr at 37˚C.
After washing using phosphate-buffered saline (PBS)/0.1% Tween, plasma samples from patients
and control donors were added at two-fold dilutions of 1:200 to 1:12,800 in PBS/0.1% casein. The
samples were incubated for 2 hr at room temperature (RT). IgG was quantified using HRP-conju-
gated goat anti-human IgG at a dilution of 1:20,000 and incubated for 1 hr. For the colour reaction,
50 ml of TMB substrate was used and stopped by adding 1 M HCl after 20 min. Absorbance was
quantified at 450 nm using a multiplate reader (CLARIOstar, BMG Labtech).
Protein microarray
Microarrays were produced at the University of California Irvine, Irvine, California, USA
(Doolan et al., 2008). In total, 262 P. falciparum proteins representing 228 unique antigens were
expressed using an Escherichia coli (E. coli) lysate in vitro expression system and spotted on a 16-
pad ONCYTE AVID slide. The selected P. falciparum antigens are known to frequently provide a
positive signal when tested with sera from individuals with sterile and naturally acquired immunity
against the parasite (Obiero et al., 2019; Dent et al., 2016; Doolan et al., 2008; Felgner et al.,
2013). For the detection of binding antibodies, secondary IgG antibody (goat anti-human IgG
QDot800; Grace Bio-Labs #110635), secondary IgM antibody (biotin-SP-conjugated goat anti-human
IgM; Jackson ImmunoResearch #109-065-043), and Qdot585 Streptavidin Conjugate (Invitrogen
#Q10111MP) were used (Taghavian et al., 2018).
Study serum samples as well as the positive and European control sera were diluted 1:50 in 0.05X
Super G Blocking Buffer (Grace Bio-Labs, Inc) containing 10% E. coli lysate (GenScript, Piscataway,
NJ) and incubated for 30 min on a shaker at RT. Meanwhile, microarray slides were rehydrated using
0.05X Super G Blocking buffer at RT. Rehydration buffer was subsequently removed and samples
added onto the slides. Arrays were incubated overnight at 4˚C on a shaker (180 rpm). Serum samples
were removed the following day and microarrays were washed using 1X TBST buffer (Grace Bio-
Labs, Inc). Secondary antibodies were then applied at a dilution of 1:200 and incubated for 2 hr at
RT on the shaker, followed by another washing step and a 1 hr incubation in a 1:250 dilution of
Qdot585 Streptavidin Conjugate. After a final washing step, slides were dried by centrifugation at
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500 g for 10 min. Slide images were taken using the ArrayCAM Imaging System (Grace Bio-Labs)
and the ArrayCAM 400 s Microarray Imager Software.
Microarray data were analyzed in R statistical software package version 3.6.2. All images were
manually checked for any noise signal. Each antigen spot signal was corrected for local background
reactivity by applying a normal-exponential convolution model (McGee and Chen, 2006) using the
RMA-75 algorithm for parameter estimation (available in the LIMMA package v3.28.14) (Silver et al.,
2009). Data was log2-transformed and further normalized by subtraction of the median signal inten-
sity of mock expression spots on the particular array to correct for background activity of antibodies
binding to E. coli lysate. After log2 transformation, data approached normal distribution. Differential
antibody levels (protein array signal) in the different patient groups were determined by Welch-cor-
rected Student’s t-test. Antigens with p<0.05 and a fold change >2 of mean signal intensities were
defined as differentially recognized between the tested sample groups. Volcano plots were gener-
ated using the PAA package (Turewicz et al., 2016) and GraphPad Prism 8. Individual antibody
breadths were defined as the number of seropositive features with signal intensities exceeding an
antigen-specific threshold set at six standard deviations above the mean intensity in negative control
samples.
Unsupervised random forest model
An unsupervised random forest (RF) model, a machine learning method based on multiple classifica-
tion and regression trees, was calculated to estimate proximity between patients. Variable impor-
tance was calculated, which shows the decrease in prediction accuracy if values of a variable are
permuted randomly. The k-medoids clustering method was applied on the proximity matrix to group
patients according to their serological profile. Input data for random forest were Luminex measure-
ments for MSP1, AMA1, and CSP reduced by principal component analysis (PCA; first principal com-
ponent selected), mADRB, and ELISA, and antibody breadths of IgG and IgM determined by protein
microarray were used to fit the RF model. Multidimensional scaling was used to display patient clus-
ter. All analyses were done with R (4.02) using the packages randomForest (4.6–14) to run RF models
and cluster (2.1.0) for k-medoids clustering.
Patient classification according to severity
Severity was defined in line with the WHO criteria for severe malaria in adults (World Health Organi-
zation (WHO), 2014). Patients were considered as having severe malaria if they showed signs of
impaired organ function (e.g., jaundice, renal failure, and cerebral manifestations) or had extremely
high parasitaemia (>10%). In addition, patients #1 and #26 were included into the severe group due
to circulating schizonts indicative of a very high sequestering parasite biomass associated with sever-
ity (Bernabeu et al., 2016; Supplementary file 2).
DNA purification and MSP1 genotyping
Genomic DNA was isolated using the QIAamp DNA Mini Kit (Qiagen) according to the manufac-
turer’s protocol. To assess the number of P. falciparum genotypes present in the patient isolates,
MSP1 genotyping was carried out as described elsewhere (Robert et al., 1996).
RNA extraction, RNA-seq library preparation, and sequencing
TRIzol samples were thawed, mixed rigorously with 0.2 volumes of cold chloroform,and incubated
for 3 min at RT. After centrifugation for 30 min at 4˚C and the maximum speed, the supernatant was
carefully transferred to a new tube and mixed with an equal volume of 70% ethanol. Subsequently,
the manufacturer’s instructions from the RNeasy MinElute Kit (Qiagen) were followed with DNase
digestion (DNase I, Qiagen) for 30 min on column. Elution of the RNA was carried out in 14 ml.
Human globin mRNA was depleted from all samples except from samples #1 and #2 using the GLO-
BINclear kit (ThermoFisher Scientific). The quality of the RNA was assessed using the Agilent 6000
Pico kit with Bioanalyzer 2100 (Agilent), and the RNA quantity was assessed using the Qubit RNA
HA assay kit and a Qubit 3.0 fluorometer (ThermoFisher Scientific). Upon arrival at BGI Genomics Co
(Hong Kong), the RNA quality of each sample was double-checked before sequencing. The median
RIN value over all ex vivo samples was 6.75 (IQR: 5.93–7.40) (Figure 2—figure supplement 4),
although this measurement has only limited significance for samples containing RNA of two species.
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Customized library construction in accordance with Tonkin-Hill et al., 2018, including amplification
with KAPA polymerase and HiSeq 2500 100 bp paired-end sequencing, was also performed by BGI
Genomics Co (Hong Kong).
RNA-seq read mapping and data analysis
Differential expression of core genes
Differential gene expression analysis of P. falciparum core genes was done in accordance with Ton-
kin-Hill et al., 2018), using the scripts available in the GitHub repository (https://github.com/gton-
kinhill/falciparum_transcriptome_manuscript/tree/master/all_gene_analysis). In brief, subread-align
v1.4.6 (Liao et al., 2013) was used to align the reads to the Homo sapiens (H. sapiens) and P. falci-
parum reference genomes. Read counts for each gene were obtained with FeatureCounts v1.20.2
(Liao et al., 2014). To account for parasite life cycle, each sample was considered as a composition
of six parasite life cycle stages, excluding the ookinete stage (López-Barragán et al., 2011).
Unwanted variations were determined with the ’RUV’ (Remove Unwanted Variation) algorithm imple-
mented in the R package ruv v0.9.6 (Gagnon-Bartsch and Speed, 2012) adjusting for systematic
errors of unknown origin by using the genes with the 1009 lowest p-values as controls as described
in Vignali et al., 2011. The gene counts and estimated ring-stage factor, and factors of unwanted
variation were then used as inputs for the Limma/Voom (Law et al., 2014; Smyth, 2005) differential
analysis pipeline.
Functional enrichment analysis of differentially expressed core genes
Genes that were identified as significantly differentially expressed (defined as  1 < logFC > 1,
p<0.05) during prior differential gene expression analysis were used for functional enrichment analy-
sis using the R package gprofiler2 (Kolberg et al., 2020). Enrichment analysis was performed on
multiple input lists containing genes expressed significantly higher (logFC >1, p<0.05) and lower
(logFC <-1, p<0.05) between different patient cohorts. All var genes were excluded from the enrich-
ment analysis. For custom visualization of results, gene set data sources available for P. falciparum
were downloaded from gprofiler (Raudvere et al., 2019). Pathway data available in the KEGG data-
base (https://www.kegg.jp/kegg/) was accessed via the KEGG API using KEGGREST (Tenen-
baum, 2020) to supplement gprofiler data sources and build a custom data source in Gene Matrix
Transposed file format (*.gmt) for subsequent visualization. Functional enrichment results were then
output to a Generic Enrichment Map (GEM) for visualization using the Cytoscape EnrichmentMap
app (Merico et al., 2010) and RCy3 (Gustavsen et al., 2019). Bar plots of differential gene expres-
sion values for genes of selected KEGG pathways were generated using ggplot2 (Wickham, 2016)
and enriched KEGG pathways were visualized using KEGGprofile (Zhao et al., 2020).
Var gene assembly
Samples from patient #1 and #2 not subjected to globin-mRNA depletion due to their low RNA con-
tent after multiple rounds of DNase treatment showed low percentages of P. falciparum-specific
reads (12.4% and 15.68%) (Supplementary file 2). Consequently, less than one million P. falciparum
reads were obtained for each of these samples, and they were omitted from assembly due to low
coverage, but included in the differential gene expression analysis.
Var genes were assembled using the pipeline described in Tonkin-Hill et al., 2018. The separate
assembly approach was chosen since it reduces the risk for generating false chimeric genes and
results in longer contigs compared to the combined all sample assembly approach. Briefly, non-var
reads were first filtered out by removing reads that aligned to H. sapiens, P. vivax, or non-var P. falci-
parum. Assembly of the remaining reads was then performed using a pipeline combining SOAPde-
novo-Trans and Cap3 (Xie et al., 2014; Huang and Madan, 1999; Liao et al., 2013). Finally,
contaminants were removed from the resulting contigs and they were then translated into the cor-
rect reading frame. Reads were mapped to the contigs using BWA-MEM (Li, 2013) and RPKM values
were calculated for each var transcript to compare individual transcript levels in each patient.
Although transcripts might be differentially covered by RNA-seq due to their variable GC content,
this seems not to be an issue between var genes (Tonkin-Hill et al., 2018).
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Var transcript differential expression
Expression of the assembled var genes was quantified using Salmon v0.14.1 (Patro et al., 2017) for
531 transcripts with five read counts in at least three patient isolates. Both the naive and pre-
exposed groups as well as the severe and non-severe groups were compared. The combined set of
all de novo assembled transcripts was used as a reference. As the RNA-seq reads from each sample
were assembled independently it is possible for a highly similar transcript to be present multiple
times in the combined set of transcripts from all samples. The Salmon algorithm identifies equiva-
lence sets between transcripts, allowing a single read to support the expression of multiple tran-
scripts. As a result, Salmon accounts for the redundancy present in our whole set of var gene contigs
from all separate sample-specific assemblies. To confirm the suitability of this approach, we also ran
the Corset algorithm as used in Tonkin-Hill et al., 2018 and Davidson and Oshlack, 2014. Unlike
Salmon, which attempts to quantify the expression of transcripts themselves, Corset copes with the
redundancy present in de novo transcriptome assemblies by clustering similar transcripts together
using both the sequence identity of the transcripts as well as multi-mapping read alignments. Of the
transcripts identified using the Salmon analysis, 5/15 in the naive versus pre-exposed and 4/13 in the
severe versus non-severe were identified in the significant clusters produced using Corset. As the
two algorithms take very different approaches and as Salmon is quantifying transcripts rather than
the ‘gene’ like clusters of Corset, this represents a fairly reasonable level of concordance between
the two methods. However, due to the high diversity in var genes, both of these approaches are
only able to identify significant associations between transcripts and phenotypes when there is suffi-
cient similarity within the associated sequences. In both the Salmon and Corset pipelines, differential
expression analysis of the resulting var expression values was performed using DESeq2 v1.26
(Love et al., 2014). The Benjamini-Hochberg method was used to control for multiple testing
(Benjamini and Hochberg, 1995).
To check the differential expression of the conserved var gene variants var1-3D7, var1-IT, and
var2csa, raw reads were mapped with BWA-MEM (AS score >110) to the reference genes from the
3D7 and the IT strains. The mapped raw read counts (bam files) were normalized with the number of
3D7 mappable reads in each isolate using bamCoverage by introducing a scaling factor to generate
bigwig files displayed in Artemis (Carver et al., 2012).
Var domain and homology block differential expression
Differential expression analysis at the domain and homology level was performed using a similar
approach to that described previously (Tonkin-Hill et al., 2018). Initially, the domain families and
homology blocks defined in Rask et al. were annotated to the assembled transcripts using HMMER
v3.1b2 (Rask et al., 2010; Eddy, 2011). Domains and homology blocks previously identified to be
significantly associated with severe disease in Tonkin-Hill et al., 2018) were also annotated by single
pairwise comparison in the assembled transcripts using USEARCH v11.0.667 (Tonkin-Hill et al.,
2018; Edgar, 2010). Overall, 336 contigs (5.22% of all contigs > 500 bp) possess partial domains in
an unusual order, for example, an NTS in an internal region or a tandem arrangement of two DBLa
or CIDRa domains. This might be caused by de novo assembly errors, which is challenging from tran-
scriptome data. Therefore, in both cases, the domain or homology block with the most significant
alignment was taken as the best annotation for each region of the assembled var transcripts (E-value
cut off of 1e-8). The expression at each of these annotations was then quantified using featureCounts
v1.6.4 before the counts were aggregated to give a total for each domain and homology block fam-
ily in each sample. Finally, similar to the transcript level analysis, DESeq2 was used to test for differ-
ences in expression levels of both domain and homology block families in the naive versus pre-
exposed groups as well as the severe versus non-severe groups. Again, more than five read counts
in at least three patient isolates were required for inclusion into differential expression analysis.
DBLa-tag sequencing
For DBLa-tag PCR, the forward primer varF_dg2 (5’-tcgtcggcagcgtcagatgtgtataagagacagGCAMG
MAGTTTYGCNGATATWGG-3’) and the reverse primer brlong2 (5’-gtctcgtgggctcggagatgtgtataaga-
gacagTCTTCDSYCCATTCVTCRAACCA-3’) were used resulting in an amplicon size of 350–500 bp
(median 422 bp) plus the 67 bp overhang (small type). Template cDNA (1 ml) was mixed with 5x
KAPA HiFi buffer, 0.3 mM of each dNTP, 2 mM of each primer and 0.5 U KAPA HiFi Hotstart
Wichers et al. eLife 2021;10:e69040. DOI: https://doi.org/10.7554/eLife.69040 21 of 30
Research article Chromosomes and Gene Expression Microbiology and Infectious Disease
Polymerase in a final reaction volume of 25 ml. Reaction mixtures were incubated at 95˚C for 2 min
and then subjected to 35 cycles of 98˚C for 20 s, 54˚C for 30 s, and 68˚C for 75 s with a final elonga-
tion step at 72˚C for 2 min. For the first five cycles, cooling from denaturation temperature was per-
formed to 65˚C at a maximal ramp of 3˚C per second, then cooled to 54˚C with a 0.5˚C per second
ramp. Heating from annealing temperature to elongation temperature was performed with 1˚C per
second, all other steps with a ramp of 3˚C per second. Agarose gel images taken afterwards showed
clean amplicons. The DBLa-tag primers contain an overhang, which was used to conduct a second
indexing PCR reaction using sample-specific indexing primers as described in Nag et al., 2017. The
overhang sequence also serves as annealing site for Illumina sequencing primers, and indexing pri-
mers include individual 8-base combinations and adapter sequences that will allow the final PCR
product to bind in MiSeq Illumina sequencing flow cells. Indexing PCR reactions were performed
with a final primer concentration of 0.065 mM and 1 ml of first PCR amplicon in a final volume of 20 ml
using the following steps: heat activation at 95˚C, 15 min, 20 cycles of 95˚C for 20 s, 60˚C for 1 min
and 72˚C for 1 min, and one final elongation step at 72˚C for 10 min. Indexing PCR amplicons were
pooled (4 ml of each) and purified using AMPure XP beads (Beckman Coulter, California, United
States) according to the manufacturer’s protocol, using 200 ml pooled PCR product and 0.6 x PCR-
pool volume of beads, to eliminate primer dimers. The purified PCR pools were analyzed on agarose
gels and Agilent 2100 Bioanalyser to verify the elimination of primer dimers and correct amplicon
sizes. Concentration of purified PCR pools was measured by Nanodrop2000 (Thermo Fisher Scien-
tific, Waltham, MA, USA), and an aliquot adjusted to 4 nM concentration was pooled with another
unrelated DNA material and added to an Illumina MiSeq instrument for paired-end 300 bp reads
using a MiSeq v3 flow cell.
DBLa-tag sequence analysis
The paired-end DBLa-tag sequences were identified and partitioned into the correct sample origin
based on unique index sequences. Each indexed raw sequence-pair was then processed through the
Galaxy webtool (usegalaxy.eu). Read quality checks were first performed with FastQC to ensure a
good NGS run (sufficient base quality, read length, duplication etc.). Next, the sequences were
trimmed by the Trimmomatic application, with a four-base sliding window approach and a Phred
quality score above 20 to ensure high sequence quality output. The trimmed sequences were then
paired and converted, following analysis using the Varia tool for quantification and prediction of the
domain composition of the full-length var sequences from which the DBLa-tag originated
(Mackenzie et al., 2020). In brief, Varia clusters DBLa-tags with 99% sequence identity using
Vsearch program (v2.14.2), and each unique tag is used to search a database consisting of roughly
235,000 annotated var genes for near identical var sequences (95% identity over 200 nucleotides).
The domain composition of all ‘hit’ sequences is checked for conflicting annotations, and the most
likely domain composition is retuned. The tool validation indicated prediction of correct domain
compositions for around 85% of randomly selected var tags, with a higher hit rate and accuracy of
the N-terminal domains. An average of 2,223.70 reads per patient sample was obtained, and clus-
ters consisting of less than 10 reads were excluded from the analysis. The raw Varia output file is
given in Supplementary file 10. The proportion of transcripts encoding a given PfEMP1 domain
type or subtype was calculated for each patient. These expression levels were used to first test the
hypothesis that N-terminal domain types associated with EPCR are found more frequently in first-
time infections or upon severity of disease, while those associated with non-EPCR binding were asso-
ciated with pre-exposed or mild cases. Secondly, quantile regression was used to calculate median
differences (with 95% confidence intervals) in expression levels for all main domain classes and sub-
types between severity and exposure groups. All analyses were done with R (4.02) using the package
quantreg (5.73) for quantile regression.
For the comparison of both approaches, DBLa-tag sequencing and RNA-seq, only RNA-seq con-
tigs spanning the whole DBLa-tag region were considered. All conserved variants, the subfamilies
var1, var2csa, and var3, detected by RNA-seq, were omitted from analysis since they were not prop-
erly amplified by the DBLa-tag primers. To scan for the occurrence of DBLa-tag sequences within
the contigs assembled from the RNA-seq data, we applied BLAST (basic local alignment search tool)
v2.9.0 software (Altschul et al., 1990). Therefore, we created a BLAST database from the RNA-seq
assemblies and screened for the occurrence of those DBLa-tag sequence with more than 97% per-
cent sequence identity using the ‘megablast option’.
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Calculation of the proportion of RNA-seq data covered by DBLa-tag was done with the upper
75th percentile based on total RPKM values determined for each patient. Vice versa, only DBLa-tag
clusters with more than 10 reads were considered and percent coverage of reads and clusters calcu-
lated for each individual patient.
For all samples, the agreement between the two molecular methods DBLa-tag sequencing and
RNA-seq was analyzed with a Bland-Altman plot, each individually, and summarized. The ratios
between %-transformed measurements are plotted on the y-axis and the mean of the respective
DBLa-tag and RNA-seq results is plotted on the x-axis. The bias and the 95% limits of agreement
were calculated using GraphPad Prism 8.4.2.
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